Steatohepatitis Stocks List

Steatohepatitis Stocks Recent News

Date Stock Title
May 17 TERN Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
May 17 IONS Ionis, Biogen Down on Ending Development of ALS Drug
May 17 VKTX 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
May 17 IONS Ionis (IONS), Biogen Down on Ending Development of ALS Drug
May 16 VKTX Viking falls after Roche’s obesity drug data; RayJay upgrades (update)
May 16 IONS Biogen also drops collaboration with Ionis on Angelman syndrome candidate
May 16 IONS Biogen and Ionis drop ALS candidate after trial setback
May 16 SGMT Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
May 16 IONS Biogen, Ionis shelve ALS drug following study failure
May 16 SGMT Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024
May 16 IONS REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
May 16 IONS Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16 IONS Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
May 16 IONS Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome
May 15 VKTX Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
May 15 VKTX Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
May 15 SGMT Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 15 IONS Ionis to host 2024 virtual Annual Meeting of Stockholders
May 14 VKTX How Is The Market Feeling About Viking Therapeutics?
May 14 PLRX Pliant reports phase 2 data on idiopathic pulmonary fibrosis asset bexotegrast
Steatohepatitis

Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes.There are two main types of fatty liver disease: alcohol-related fatty liver disease and non-alcoholic fatty liver disease (NAFLD). Risk factors for NAFLD include diabetes, obesity and metabolic syndrome. When inflammation is present it is referred to as alcoholic steatohepatitis and nonalcoholic steatohepatitis (NASH). Steatohepatitis of either cause may progress to cirrhosis, and NASH is now believed to be a frequent cause of unexplained cirrhosis (at least in Western societies). NASH is also associated with lysosomal acid lipase deficiency.The word is from steato-, meaning "fat" and hepatitis, meaning "inflammation of the liver".

Browse All Tags